Periodontal Disease Treatment Market to Register a Strong
Growth Rate Upto 2030
Periodontal Disease Treatment Market research
report by Delvens focuses on primary sections such as – market segments, market
outlook, competitive landscape, and company profiles. The segments provide
details in terms of various perspectives such as end-use industry, product or
service type, and any other relevant segmentation as per the market’s current
scenario which includes various aspects to perform further marketing activity, The
Periodontal Disease Treatment market size was estimated at USD 799.17 million
in 2023 and is projected to reach USD 1438.54 million in 2030 at a CAGR of
8.76% during the forecast to 2030.
Get Free Sample
Report: https://www.delvens.com/get-free-sample/periodontal-disease-treatment-market
The growth of the periodontal disease treatment market can
be attributed to several factors. The increasing awareness about oral health
and the consequences of untreated periodontal disease is driving the demand for
treatment options. Moreover, as the global population ages, the prevalence of
periodontal diseases tends to increase, leading to a higher demand for the
treatment.
Recent Developments
·
Novo Nordisk collaborated with Aspect
Biosystems, a company involved in bioprinting biomaterials, for the development
of bioprinted tissue therapeutics for obesity and diabetes.
·
Biocomposites signed an agreement with Zimmer
Biomet to distribute the new genex Bone Graft Substitute. Genex Bone Graft
Substitute is a biphasic composite of exceptional purity specifically formulated
to balance osteoconductive scaffold strength and persistence in the body to
enable the optimal remodeling of bone architecture.
North America to
Dominate the Market
North America is estimated to account for the largest market
share during the forecast period. This is because of the presence of major key
players in the region and growing initiatives by the local government for the
improvement of oral care.
Moreover, provision of knowledgeable dental workforce to
address the high unmet needs in this region is expected to drive the market
during the forecast period.
The Prominent Players
in the Periodontal Disease Treatment Market:
·
3M
·
Bausch Health Companies Inc.
·
Biohorizons Implant Systems Inc.
·
Colgate-Palmolive Company Limited
·
Danaher Corporation
·
Den-Mat Holdings LLC
·
Dexcel Pharma
·
Institut Straumann AG
·
Mylan N.V.
·
Noveome Biotherapeutics, Inc
·
Pfizer Inc
·
Sunstar Suisse S.A
·
Tolmar Pharmaceuticals, Inc and More
Key Findings:
·
Based on type, the market is segmented into
gingivitis, chronic periodontal disease, aggressive periodontal disease,
others. Gingivitis dominated the market in this segment. This is because
gingivitis is one of the most common types of periodontitis.
·
Based on treatment type, the market can be
segmented into non-surgical treatment, surgical treatment. Non-surgical
treatments dominated the market in this segment. This is because surgical
procedures are not often recommended as compared to non-surgical procedures
such as systematic antibiotics therapies.
·
Based on drugs, the market is segmented into
systematic antibiotics, local antibiotics. The systematic antibiotics dominated
the market in this segment. This can because systematic antibiotics are less
invasive than surgery, less painful, and take less time to complete.
·
Based on route of administration the market is
segmented into oral, injectable. The oral route dominated the market in this
segment. This is because the oral route is the most common route of administration
for periodontal dental treatments as drugs are administered orally in the form
of tablets, capsules, or liquids.
·
Based on End-User, the market is segmented into
hospitals, dental clinic, dental academics and research institutes,
others. Dental Clinics dominated the
market in this segment as for most of the dental-related problems, people
prefer to consult a dentist.
Access Full Report: https://www.delvens.com/report/periodontal-disease-treatment-market
In addition to the
market data for the Periodontal Disease Treatment Market, Delvens offers
client-centric reports customized according to the company’s specific demand
and requirements.
Access More Related
Reports:
Immunohistochemistry (IHC) Market
About Us:
Delvens is a strategic advisory and consulting company
headquartered in New Delhi, India. The company holds expertise in providing
syndicated research reports, customized research reports and consulting
services. Delvens qualitative and quantitative data is highly utilized by each
level from niche to major markets, serving more than 1K prominent companies by
assuring to provide the information on country, regional and global business
environment. We have a database for more than 45 industries in more than 115+
major countries globally.
Delvens database assists the clients by providing in-depth
information in crucial business decisions. Delvens offers significant facts and
figures across various industries namely Healthcare, IT & Telecom,
Chemicals & Materials, Semiconductor & Electronics, Energy,
Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our
company provides an exhaustive and comprehensive understanding of the business
environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301,
IN
+44 20 3290 6466
+0120- 4903958
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.